Cinaciguat


Cinaciguat is an experimental drug for the treatment of acute decompensated heart failure.

Mechanism of action

Cinaciguat activates the soluble guanylate cyclase which is a receptor for nitric oxide. This increases biosynthesis of cyclic GMP, resulting in vasodilation.